Sumi Toshiyuki

スミトシユキ | Sumi Toshiyuki

Affiliation and department：
Other affiliations (1)：

Research field (1)： Respiratory medicine

Research theme for competitive and other funds (3)：

2018 - 2021 Development of a selective culture method for pulmonary epithelial stem cells using high-performance immunotoxin
2017 - 2019 Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung
2016 - 2018 Basic examination of survivin as therapeutic targets in KRAS-mutant lung adenocarcinoma

Papers (78)：

Toshiyuki Sumi, Keito Suzuki, Kotomi Arioka, Hirofumi Chiba. Methotrexate-associated lymphoproliferative disorder of the heart. Japanese Journal of Clinical Oncology. 2024
Toshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, Takumi Ikeda, Yuta Koshino, Keito Suzuki, Kotomi Arioka, Yuichi Yamada, Hirofumi Chiba. Transesophageal ultrasound-guided bronchoscopic Acquire TBNB versus Vizishot2 TBNA needles for neoplastic lesions: A retrospective study. Respiratory Investigation. 2024
Miki Yamaguchi, Sachie Hirai, Masashi Idogawa, Toshiyuki Sumi, Hiroaki Uchida, Yuji Sakuma. A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells. International journal of molecular sciences. 2024. 25. 16
Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino, Daiki Nagayama, Yuta Nagahisa, Keigo Matsuura, Naoki Shijubou, Koki Kamada, Keito Suzuki, Takumi Ikeda, et al. Risk factors for severe immune-related pneumonitis after nivolumab plus ipilimumab therapy for non-small cell lung cancer. Thoracic Cancer. 2024
Naoki Shijubou, Toshiyuki Sumi, Terufumi Kubo, Kenta Sasaki, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Yoshiko Keira, Kotomi Terai, Tatsuru Ikeda, et al. Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors. Journal of Cancer Research and Clinical Oncology. 2024

ｍore...

MISC (115)：

角俊行, 十良澤太門, 鈴木敬仁, 越野友太, 池田拓海, 渡辺裕樹, 山田裕一, 千葉弘文. ニボルマブ+イピリムマブ+プラチナ併用療法施行中,胸膜癒着術後にサイトカイン放出症候群をきたした肺腺癌の1例. 肺癌. 2023. 63. 7. 971-976
鈴木敬仁, 角俊行, 越野友太, 池田拓海, 山田裕一. 肺腺癌術後の癌性リンパ管症をクライオ生検で診断した1例. 気管支学. 2023. 45. 6. 441-441
角俊行, 鈴木敬仁, 越野友太, 池田拓海, 山田裕一. アクワイヤー超音波内視鏡下穿刺針を用いたEUS-B-FNBの検討. 気管支学. 2023. 45. 6. 441-442
角俊行, 戸塚猛大, 突田容子, 久代航平, 細川忍, 教山紘之, 鶴見恭士, 鈴木洋平, 石川大輔, 吉村成央, et al. 高齢者・フレイルな患者への対応策高齢非小細胞肺癌患者における殺細胞免疫併用療法の有効性/安全性を検討する多機関後方視的研究(NEJ057). 肺癌. 2023. 63. 5. 375-375
浅地菜々子, 表俊輔, 角俊行, 山田裕一, 上原浩文, 中釜郁. III・IV期および終末期肺癌症例に対するリハビリテーションの現状. 肺癌. 2023. 63. 5. 441-441

ｍore...

Books (1)：

Education (2)：

Professional career (1)：

Work history (8)：

Show all

Committee career (1)：

Association Membership(s) (5)：

日本呼吸器内視鏡学会 , 日本アレルギー学会 , 日本肺癌学会 , 日本呼吸器学会 , 日本内科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page